Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer - author's reply

被引：1
作者：
Hong, Hyeyeon [1 ]
Choi, Jonggi [1 ]
机构：
[1] Univ Ulsan, Liver Ctr, Asan Med Ctr, Dept Gastroenterol,Coll Med, Seoul, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2024年 / 30卷 / 02期
基金：
新加坡国家研究基金会;
关键词：
Antiviral agent; Tenofovir; Lipid; DOUBLE-BLIND; PHASE-3;
D O I：
10.3350/cmh.2024.0123
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 8 条
  • [1] 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection
    Agarwal, Kosh
    Brunetto, Maurizia
    Seto, Wai Kay
    Lim, Young-Suk
    Fung, Scott
    Marcellin, Patrick
    Ahn, Sang Hoon
    Izumi, Namiki
    Chuang, Wan-Long
    Bae, Ho
    Sharma, Manoj
    Janssen, Harry L. A.
    Pan, Calvin Q.
    Celen, Mustafa Kemal
    Furusyo, Norihiro
    Shalimar, Dr
    Yoon, Ki Tae
    Huy Trinh
    Flaherty, John F.
    Gaggar, Anuj
    Lau, Audrey H.
    Cathcart, Andrea L.
    Lin, Lanjia
    Bhardwaj, Neeru
    Suri, Vithika
    Subramanian, G. Mani
    Gane, Edward J.
    Buti, Maria
    Chan, Henry L. Y.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 (04) : 672 - 681
  • [2] Buti M, 2016, LANCET GASTROENTEROL, V1, P90, DOI [10.1016/S2468-1253(16)30020-6, 10.1016/S2468-1253(16)30107-8]
  • [3] Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate
    Byun, Kwan Soo
    Choi, Jonggi
    Kim, Ji-Hoon
    Lee, Yung Sang
    Lee, Han Chu
    Kim, Yoon Jun
    Yoo, Byung Chul
    Kwon, So Young
    Gwak, Geum-Youn
    Lim, Young-Suk
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) : 427 - 437
  • [4] Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B
    Cheng, Pin-Nan
    Feng, I-Cher
    Chen, Jyh-Jou
    Kuo, Hsing-Tao
    Lee, Pei-Lun
    Yu, Ming-Lung
    Chiu, Yen-Cheng
    Chiu, Hung-Chih
    Chien, Shih-Chieh
    Chen, Pei-Jer
    Liu, Chun-Jen
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 230 - 238
  • [5] Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (01) : 49 - 63
  • [6] Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis
    Jeong, Joonho
    Shin, Jung Woo
    Jung, Seok Won
    Park, Eun Ji
    Park, Neung Hwa
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2022, 28 (02) : 254 - 264
  • [7] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
    Lampertico, Pietro
    Buti, Maria
    Fung, Scott
    Ahn, Sang Hoon
    Chuang, Wan-Long
    Tak, Won Young
    Ramji, Alnoor
    Chen, Chi-Yi
    Tam, Edward
    Bae, Ho
    Ma, Xiaoli
    Flaherty, John F.
    Gaggar, Anuj
    Lau, Audrey
    Liu, Yang
    Wu, George
    Suri, Vithika
    Tan, Susanna K.
    Subramanian, G. Mani
    Trinh, Huy
    Yoon, Seung-Kew
    Agarwal, Kosh
    Lim, Young-Suk
    Chan, Henry L. Y.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (05): : 441 - 453
  • [8] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive chronic hepatitis B
    Lim, Jihye
    Choi, Won-Mook
    Shim, Ju Hyun
    Lee, Danbi
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    [J]. LIVER INTERNATIONAL, 2022, 42 (07) : 1517 - 1527
1